App Teaches Doctors to Diagnose Skin Cancer

• Sponsor: Herlev Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT05661370
• Collaborator: (none)
• Enrollment: 117
• Location: 1
• Arms: 2
• Actual Duration (Months): 9
• Patients Per Site Per Month: 13

Study Details

Study Description

Brief Summary

This study aimed to examine if self-paced learning with a novel digital patient-case-based educational platform can increase primary care physicians' diagnostic accuracy of malignant and benign skin lesions on both the level of benign/malignant and the diagnosis level. Secondarily the study aimed to investigate the time spent in reaching this change in proficiency.

Condition or Disease	Intervention/Treatment	Phase
Melanoma (Skin); Carcinoma	Other: Dermloop Learn	N/A

Detailed Description

Participants were given a questionnaire and an initial Skin Cancer Multiple Choice-Questionnaire (MCQ) to test their diagnostic skills regardining skin and mole cancer and the most common differential diagnoses.

Participants in the Intervention group was then given access to an educational mobile application (App) for 8 days and asked to diagnose 500 patient cases. The participants did so at their own leisure and time.

After 8 days they were asked to abstain from using the App for another 8 days (wash out period) and were then given a Final Skin Cancer Multiple Choice-Questionnaire (MCQ).

Participants of the control group received no intervention nor education during the 16 days of waiting before they took the final Skin Cancer Multiple Choice-Questionnaire.

Study Design

• Study Type: Interventional
• Actual Enrollment: 117 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Intervention Model Description: Intervention and Controlgroup parallel design using sequential continues block randomization.Intervention and Controlgroup parallel design using sequential continues block randomization.
• Masking: None (Open Label)
• Primary Purpose: Other
• Official Title: Improving Diagnostic Accuracy in Skin Cancer Diagnostics Using Educational Mobile App: a Randomized Controlled Study
• Actual Study Start Date: Nov 15, 2021
• Actual Primary Completion Date: Jan 15, 2022
• Actual Study Completion Date: Aug 15, 2022

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Intervention Access to educational mobile application for 8 days, diagnosing 500 digital patient-cases.	Other: Dermloop Learn; Educational Mobile Application with a library of digital patient-cases and written learning modules the user can access on 36 common skin lesions, both benign and malignant.
No Intervention: Control Control group receiving no intervention, continuing daily practice.

Outcome Measures

Primary Outcome Measures

1. Multiple-Choice Questionnaire (MCQ) Score [Before and immediately after intervention (On average 19 days after enrollment)]

   Participants are given a test before and after the intervention using a skin cancer MCQ test with 12 digital-patient cases. A higher score means better diagnostic proficiency. The primary outcome is the change of this score.

Secondary Outcome Measures

1. Diagnostic proficiencies [During the 8 days of access to the educational mobile application.]

   Sensitivity, Specificity and Positive Predictive Value of the participants in the intervention group, calculated on their cases seen in the educational mobile application.

2. Time spend [During the 8 days of access to the educational mobile application.]

   The Dermloop Learn app tracks how much time each user spends quizzing and reading.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Primary Care Physician who works in General Practice

Exclusion Criteria:

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	AISC Research Fascility	Copenhagen	Danmark	Denmark	2700

Sponsors and Collaborators

• Herlev Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Gustav Gede Nervil, Medical Doctor, Herlev Hospital
• ClinicalTrials.gov Identifier: NCT05661370
• Other Study ID Numbers: GP-Learn
• First Posted: Dec 22, 2022
• Last Update Posted: Dec 22, 2022
• Last Verified: Dec 1, 2022

• Individual Participant Data (IPD) Sharing Statement: Yes
• Plan to Share IPD: Yes
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Gustav Gede Nervil, Medical Doctor, Herlev Hospital: Digital Learning; e-learning; Melanoma; Carcinoma; Dermoscopy; Dermloop
• Additional relevant MeSH terms: Melanoma; Skin Neoplasms

Study Results

No Results Posted as of Dec 22, 2022